Editor´s Pick

McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine

IRVING, Texas--(BUSINESS WIRE)--As a centralized distribution partner for the U.S. government’s COVID vaccine distribution effort, McKesson today began distributing the COVID-19 vaccine received from...

Admin - March 1, 2021 0

Editor´s Pick

Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today they have begun an evaluation of the safety...

Admin - February 25, 2021 0

Editor´s Pick

Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical Trial Using Digital Therapeutics as Adjunctive Therapy in Adults With Major Depressive Disorder

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Click Therapeutics, Inc. announce the initiation of the Mirai study, a...

Admin - February 25, 2021 0

Editor´s Pick

Moderna Announces it has Shipped Variant-Specific Vaccine Candidate, mRNA-1273.351, to NIH for Clinical Study

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces that it has completed manufacturing of clinical...

Admin - February 25, 2021 0

Editor´s Pick

Moderna Announces Additional Capital Investments to Increase Global Manufacturing Capacity for COVID-19 Vaccine

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announces it is making new capital investments to...

Admin - February 25, 2021 0

Editor´s Pick

SIRION Biotech Announces Collaboration with Sanofi to Innovate Gene Therapy Treatments with Improved Adeno-Associated Virus Capsids

MUNICH--(BUSINESS WIRE)--SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced today that it signed a...

Admin - February 23, 2021 0

123...44 Page 2 of 44

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Editor´s Pick March 6, 2021

Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis

Industry News March 6, 2021

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

Industry News March 6, 2021

U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy

Regulatory Affairs March 6, 2021

Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

Clinical Trials March 6, 2021

Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic...

Industry News March 5, 2021

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan

Editor´s Pick March 5, 2021

Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol

Clinical Trials March 5, 2021

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Second- or Third-line Non-Small Cell Lung Cancer

Regulatory Affairs March 5, 2021

Ridgeback Biotherapeutics Announces Publication of Phase 1 Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses...

Clinical Trials March 4, 2021

GC Pharma Finalises Agreement With Moderna and the Government of the Republic of Korea for COVID-19 Vaccines Distribution

Editor´s Pick March 4, 2021

Editor´s Pick

Recent Articles

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy

Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic...

Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan

Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Second- or Third-line Non-Small Cell Lung Cancer

Ridgeback Biotherapeutics Announces Publication of Phase 1 Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses...

GC Pharma Finalises Agreement With Moderna and the Government of the Republic of Korea for COVID-19 Vaccines Distribution

Merck Begins Tender Offer to Acquire Pandion Therapeutics

Talaris Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer

New Research Reveals More CROs Taking Action to Meet Urgent Need for Faster Clinical Trials

Apnimed Strengthens Management Team with Addition of Leading Sleep Medicine Expert, David P. White, M.D.